Securities code: Xiangxue Pharmaceutical Co.Ltd(300147) securities abbreviation: Xiangxue Pharmaceutical Co.Ltd(300147) Announcement No.: 2022038
Xiangxue Pharmaceutical Co.Ltd(300147)
Announcement on judicial freezing of some shares held by shareholders holding more than 5%
The company and all members of the board of directors guarantee that the information disclosed is true, accurate, complete and free from falsehood
Records, misleading statements or material omissions.
Xiangxue Pharmaceutical Co.Ltd(300147) (hereinafter referred to as “the company”) recently passed the inquiry of China Securities Exchange
Shenzhen Branch System of securities registration and settlement Co., Ltd. learned that the controlling shareholder Guangzhou Kunlun Investment Co., Ltd
Part of the shares of the company held by the company (hereinafter referred to as “Kunlun investment”) have been frozen by the judiciary. The specific situation is now explained
The announcement is as follows:
1、 Freezing of shareholders’ shares
(I) freezing of shares
Whether the shareholder is the controlling shareholder, and whether the proportion of the total shares frozen this time is limited
Name and proportion of shares / shares of persons acting in concert the proportion of shares sold and the reason for freezing the executor on the starting date and expiration date
1152 0.0007% 0.0002% no 2022 / 5 / 192025 / 5 / 18 Guangzhou City, Guangdong Province
Kunlun people’s court
Investment is subject to judicial freeze 3000 0.0018% 0.0005% no 2022 / 5 / 192025 / 5 / 18 Guangzhou City, Guangdong Province
People’s court at the next level
(II) cumulative freezing of shareholders’ shares
Shareholder name shareholding number / shareholding proportion cumulative frozen shares / shares proportion of shares held proportion of total share capital
Kunlun investment 16550057825.03% 125569247.59% 1.90%
Note: 1. As of the issuance date of this announcement, Kunlun investment has pledged 165045629 shares, of which 12101975 shares have been pledged
Judicial freeze; 2. The difference in the mantissa of the calculation proportion is caused by rounding.
2、 Impact on the company
As of the disclosure date of this announcement, the company has passed the Shenzhen Branch of China Securities Depository and Clearing Co., Ltd
Except for the information inquired by the system, no legal documents or documents related to the above judicial re freezing have been received. This Kunlun
The judicial freezing of some shares of the company held by the investment will not lead to the change of the company’s control and will not affect the company
Adverse impact on production and operation. The company will continue to pay attention to the progress of the freezing of shares and comply with laws, regulations and
Please pay attention to the investment risk when performing the obligation of information disclosure.
3、 Documents for future reference
Detailed statement of securities pledge and judicial freezing of China Securities Depository and Clearing Co., Ltd.
It is hereby announced.
Xiangxue Pharmaceutical Co.Ltd(300147) board of directors may 20, 2022
